Assertio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Assertio and buy or sell other stocks, ETFs, and their options commission-free!

About ASRT

Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. 

CEO
Arthur Joseph Higgins
CEOArthur Joseph Higgins
Employees
125
Employees125
Headquarters
Lake Forest, Illinois
HeadquartersLake Forest, Illinois
Founded
1995
Founded1995
Employees
125
Employees125

ASRT Key Statistics

Market cap
1.91B
Market cap1.91B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
2.46M
Average volume2.46M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$3.63
52 Week high$3.63
52 Week low
$0.55
52 Week low$0.55

Stock Snapshot

With a market cap of 1.91B, Assertio(ASRT) trades at $23.50.

On 2026-07-03, Assertio(ASRT) stock opened at —, reached a high of —, and a low of —.

Assertio(ASRT) shares are trading with a volume of 0, against a daily average of 2.46M.

In the last year, Assertio(ASRT) shares hit a 52-week high of $3.63 and a 52-week low of $0.55.

In the last year, Assertio(ASRT) shares hit a 52-week high of $3.63 and a 52-week low of $0.55.

People also own

Based on the portfolios of people who own ASRT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.